Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or North Dakota for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to North Dakota only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. North Dakota (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Marina Gilca (NPI 1386028314)

Field	Value
Entity Type	Individual
Organization	Marina Gilca
Address	4450 31st Ave S Ste 200
City	Fargo
State	ND
ZIP	58104
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	July 20, 2015

Payer Source	Total Paid
Medicare	$4.3M
Medicaid	$0

Key Findings

This provider is effectively a single‑payer practice: total Medicare revenue is $4.3M and there is no Medicaid billing on file, so operational and reimbursement exposure is concentrated in Medicare rather than split across Medicare and Medicaid payers. That concentration should be considered when modeling payer negotiations or revenue sensitivity to Medicare policy changes.

Revenue is heavily concentrated in a small set of intravitreal drug codes: the precomputed top 3 Medicare codes account for 84.7% of this provider's total Medicare revenue, indicating the practice’s economics are driven by a narrow set of high‑revenue retinal therapies. This concentration implies business risk if utilization or reimbursement for these therapies changes.

J2777 is the single largest revenue driver, accounting for $2.2M (50.9% of Medicare revenue) with 78.1K claims; the provider ranks #35 of 2039 nationally and is labeled an "extreme outlier," indicating far higher-than‑typical faricimab utilization compared with peers. This extreme outlier status suggests either a high local demand for faricimab, specialized clinical focus on indications treated with faricimab, or unusually large drug administration volume relative to most retina specialists.

J0178 is the second major revenue source at $1.2M (29.0% of Medicare revenue) over 1.9K claims and ranks #590 of 3204 (82th percentile; typical, unremarkable volume). Together with J2777, the two intravitreal drug codes dominate the practice’s billing, but J0178’s percentile indicates its aflibercept volumes are within a typical high‑use range for retinal specialists rather than an extreme outlier.

67028 appears as the third top code with $210.4K (4.9% of Medicare revenue) across 2.2K claims and ranks #295 of 4255 (93th percentile; notably above typical national volume). This supports that the practice performs a high volume of standalone intravitreal injection procedures in addition to drug administration, consistent with a retina‑focused procedural workflow.

Several other retina‑specific services also show elevated national standing: 92134 (retinal imaging) generated $81.8K with 2.7K claims and ranks #535 of 26868 (98th percentile; extreme outlier), indicating unusually high use of diagnostic retinal imaging alongside injections. High imaging volumes coupled with dominant drug injection billing point to a vertically integrated retina service line that pairs frequent diagnostics with drug therapy.

Procedure and implant codes beyond anti‑VEGF/faricimab are present but smaller: J7312 (dexamethasone implant) produced $76.6K (504 claims) and ranks #42 of 492 (91th percentile; typical, unremarkable volume), while J2778 (ranibizumab) and J2781 (pegcetacoplan) appear at lower revenue shares. This mix shows reliance on multiple intravitreal therapies and implants, indicating a broad therapeutic toolkit but with clear revenue dominance by faricimab and aflibercept.

The provider has been enumerated since 2015-07-20 (~11 years ago), and also shows unusually high new patient E/M volumes for a single specialist: 99204 appears with 281 claims ($33.7K) and ranks #1635 of 227068 (99th percentile; extreme outlier), which suggests strong new patient intake or referral-driven new consult volume that feeds the high injection and imaging throughput.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

25 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	78,120	$30	$2.2M
J0178	Injection, aflibercept, 1 mg	1,880	$660	$1.2M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,190	$100	$210.4K
J2778	Injection, ranibizumab, 0.1 mg	590	$180	$106.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,730	$30	$81.8K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	500	$150	$76.6K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	830	$90	$72.1K
J3490	Unclassified drugs	40	$1,360	$58.3K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	480	$120	$57.7K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	40	$890	$38.4K

Showing 1–10 of 25

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. North Dakota Distribution

Marina Gilca — 13 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — North Dakota

Full comparison — all codes billed, vs. state median

25 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	2	20	440	$680	$445.3K
J2777	1	10	7,410	$30	$412.9K
J2778	2	10	680	$180	$121.4K
J7312	1	10	500	$150	$76.8K
J2781	1	10	480	$120	$57.9K
67028	1	30	290	$80	$40.6K
67042	2	10	40	$1,030	$37K
67108	1	10	20	$910	$20K
67036	1	10	20	$830	$17.5K
92014	4	170	160	$70	$15.6K

Showing 1–10 of 25

Related Providers

Other providers that share a Tax Identification Number (TIN) with Marina Gilca, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Anil Potti	ND	Hematology & Oncology Physician	$4.9M	$0
Max Johnson	ND	Retina Specialist (Ophthalmology) Physician	$2.8M	$0
Ravi Pandit	OK	Retina Specialist (Ophthalmology) Physician	$2.5M	$0
William Noyes	ND	Radiation Oncology Physician	$1.2M	$0
Deepak Mangla	MI	Ophthalmology Physician	$1M	$0
Jonathan Marshall	NY	Diagnostic Radiology Physician	$761.9K	$4.4K
Retina Consultants, Ltd	ND	Retina Specialist (Ophthalmology) Physician	$0	$625.8K
Myles Mitsunaga	CA	Diagnostic Radiology Physician	$510.8K	$113.9K
Aaron Fortney	ND	Ophthalmology Physician	$561.1K	$0
Monte Leidenix	ND	Ophthalmology Physician	$553.3K	$0

Nearby Providers

Other providers in the same ZIP code as Marina Gilca, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Pediatric Therapy Partners, Inc.	ND	Early Intervention Provider Agency	$0	$7M
Fargo Maple View LLC	ND	Alzheimer Center (Dementia Center)	$0	$4M
Beyond Boundaries Occupational Therapy, Inc.	ND	Multi-Specialty Clinic/Center	$0	$3.9M
St. Sophie's, LLC	ND	Adolescent and Children Mental Health Clinic/Center	$0	$2.7M
Shangri-la Home Care	ND	Home Health Agency	$0	$2M
Beyond Boundaries Speech Language Therapy, Inc.	ND	Speech-Language Pathologist	$0	$2M
About Smiles Dental, LLC	ND	Dental Clinic/Center	$0	$1.7M
Center For Pain Medicine Surgery Center LLC	ND	Ambulatory Surgical Clinic/Center	$1.2M	$0
Davita Dakota Dialysis Center LLC	ND	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$1.2M
Michelle Atchison	ND	Ophthalmology Physician	$872.5K	$0

Marina Gilca — Billing Profile & Reimbursement Data

Sign up for Marina Gilca — Billing Profile & Reimbursement Data policy alerts

Marina Gilca — Billing Profile & Reimbursement Data

Sign up for Marina Gilca — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References